Cancer Chemotherapy & Immunopharmacology

antimetabolite

An antimetabolite is a drug that disguises itself as a natural building block the cell needs, then sabotages the process from inside. Picture a counterfeit Lego brick: it slots into the assembly line of DNA or RNA, but once in place it either won't connect to the next piece or jams the machine. Fast-dividing cells, hungry for these building blocks, are hit hardest.

Mechanistically, antimetabolites resemble the normal substrates or cofactors used to make DNA and RNA. Some block the enzymes that produce nucleotides; methotrexate, for example, inhibits dihydrofolate reductase and starves the cell of folate-derived building blocks. Others, like 5-fluorouracil or cytarabine, are taken up as fake nucleotides and incorporated into the growing strand, blocking elongation or triggering errors. Because they mainly damage cells while DNA is being synthesised, they are largely S-phase specific.

Their cell-cycle specificity shapes both benefit and limit. They work best on rapidly cycling tumours and are often given as continuous or repeated dosing to catch more cells in S phase. The same logic explains their toxicities to the gut lining and bone marrow, and why some have specific antidotes such as folinic acid (leucovorin) rescue after high-dose methotrexate.

Many antimetabolites are also used outside cancer; methotrexate at low doses treats rheumatoid arthritis and psoriasis, where it dampens overactive immune cells.